Cytek Biosciences Ownership 2024 | Who Owns Cytek Biosciences Now?
Institutional Ownership
18.27%
Insider Ownership
8.77%
Retail Ownership
72.95%
Institutional Holders
55.00
Cytek Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 13.04% | 0.00% | 17,070,422 | -355,549 | -2.04% | 95,252,956 | Jun 30, 2024 |
| VANGUARD GROUP INC | 8.97% | 0.00% | 11,746,178 | -266,627 | -2.22% | 65,543,673 | Jun 30, 2024 |
| BROWN CAPITAL MANAGEMENT LLC | 8.70% | 1.28% | 11,387,384 | -634,630 | -5.28% | 63,541,603 | Jun 30, 2024 |
| HHLR ADVISORS, LTD. | 5.08% | 0.92% | 6,657,030 | - | - | 37,146,227 | Jun 30, 2024 |
| STATE STREET CORP | 3.03% | 0.00% | 3,973,132 | -142,727 | -3.47% | 22,170,077,000 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 2.25% | 0.02% | 2,949,008 | 1,022 | 0.03% | 16,455,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.97% | 0.00% | 2,578,794 | 70,778 | 2.82% | 14,392,599 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.63% | 0.00% | 2,135,707 | 780,737 | 57.62% | 11,917,245 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.12% | 0.00% | 1,465,122 | 89,615 | 6.52% | 8,174,767 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.04% | 0.00% | 1,357,251 | 793,236 | 140.64% | 7,573,460 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.83% | 0.00% | 1,085,387 | -45,235 | -4.00% | 6,056,459,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.72% | 0.00% | 946,490 | 919,845 | 3452.22% | 5,281,414 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.70% | 0.00% | 917,835 | 16,842 | 1.87% | 5,121,519 | Jun 30, 2024 |
| MORGAN STANLEY | 0.68% | 0.00% | 894,364 | 50,843 | 6.03% | 4,990,551 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.61% | 0.00% | 804,261 | 29,579 | 3.82% | 4,487,777 | Jun 30, 2024 |
| FMR LLC | 0.49% | 0.00% | 636,690 | 114,302 | 21.88% | 3,552,730 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.48% | 0.01% | 631,472 | -486 | -0.08% | 3,523,614 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.46% | 0.00% | 608,440 | 523,028 | 612.36% | 3,395,095 | Jun 30, 2024 |
| FIL LTD | 0.44% | 0.00% | 573,600 | - | - | 3,200,688 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.37% | 0.00% | 480,144 | -38,550 | -7.43% | 2,679,204,000 | Jun 30, 2024 |
Cytek Biosciences's largest institutional shareholder is BLACKROCK INC., holding 13.04% of the company's total share outstanding, currently valued at $95.25M. The top 10 institutional shareholders own together 46.84% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BROWN CAPITAL MANAGEMENT LLC | 8.70% | 1.28% | 11,387,384 | -634,630 | -5.28% | 63,541,603 | Jun 30, 2024 |
| HHLR ADVISORS, LTD. | 5.08% | 0.92% | 6,657,030 | - | - | 37,146,227 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.23% | 0.05% | 295,275 | 168,665 | 133.22% | 1,648,000 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.02% | 0.03% | 29,984 | -55,850 | -65.07% | 167,311 | Jun 30, 2024 |
| VERSOR INVESTMENTS LP | 0.02% | 0.02% | 22,400 | -24,500 | -52.24% | 124,992 | Jun 30, 2024 |
| STATE OF WYOMING | 0.02% | 0.02% | 23,871 | 6,233 | 35.34% | 133,200 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 2.25% | 0.02% | 2,949,008 | 1,022 | 0.03% | 16,455,000 | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | 0.02% | 0.02% | 21,098 | 9,711 | 85.28% | 117,727 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.48% | 0.01% | 631,472 | -486 | -0.08% | 3,523,614 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.02% | 0.01% | 23,470 | 6,524 | 38.50% | 131,000 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.12% | 0.01% | 155,759 | 155,759 | 100.00% | 869,135 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.11% | 0.01% | 138,394 | 138,394 | 100.00% | 772,239 | Jun 30, 2024 |
| NORTHCREST ASSET MANANGEMENT, LLC | 0.04% | 0.01% | 51,150 | - | - | 285,417 | Jun 30, 2024 |
| SLATESTONE WEALTH, LLC | 0.01% | 0.01% | 12,500 | 12,500 | 100.00% | 70,000 | Jun 30, 2024 |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 0.16% | 0.01% | 210,813 | 5,476 | 2.67% | 1,176,337 | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.01% | 0.01% | 16,914 | 1,114 | 7.05% | 94,380 | Jun 30, 2024 |
| CORNERSTONE INVESTMENT PARTNERS, LLC | 0.02% | 0.01% | 23,554 | -1,900 | -7.46% | 131,431 | Jun 30, 2024 |
| ROYCE & ASSOCIATES LP | 0.09% | 0.01% | 119,478 | 108,128 | 952.67% | 666,687 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.01% | 0.01% | 14,647 | 14,647 | 100.00% | 82,000 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.20% | 0.01% | 257,527 | -250,065 | -49.27% | 1,437,001 | Jun 30, 2024 |
The largest Cytek Biosciences shareholder by % of total assets is BROWN CAPITAL MANAGEMENT LLC. The company owns 11.39M shares of Cytek Biosciences (CTKB), representing 1.28% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 0.72% | 0.00% | 946,490 | 919,845 | 3452.22% | 5,281,414 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.04% | 0.00% | 1,357,251 | 793,236 | 140.64% | 7,573,460 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.63% | 0.00% | 2,135,707 | 780,737 | 57.62% | 11,917,245 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.46% | 0.00% | 608,440 | 523,028 | 612.36% | 3,395,095 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.18% | 0.00% | 233,900 | 233,900 | 100.00% | 1,305,162 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.14% | 0.00% | 187,361 | 170,539 | 1013.79% | 1,045,474 | Jun 30, 2024 |
| ALGERT GLOBAL LLC | 0.23% | 0.05% | 295,275 | 168,665 | 133.22% | 1,648,000 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.12% | 0.01% | 155,759 | 155,759 | 100.00% | 869,135 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.11% | 0.01% | 138,394 | 138,394 | 100.00% | 772,239 | Jun 30, 2024 |
| FMR LLC | 0.49% | 0.00% | 636,690 | 114,302 | 21.88% | 3,552,730 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.15% | 0.00% | 201,755 | 112,388 | 125.76% | 1,125,794 | Jun 30, 2024 |
| ROYCE & ASSOCIATES LP | 0.09% | 0.01% | 119,478 | 108,128 | 952.67% | 666,687 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.12% | 0.00% | 1,465,122 | 89,615 | 6.52% | 8,174,767 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.15% | 0.00% | 199,153 | 75,022 | 60.44% | 1,111,274 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.97% | 0.00% | 2,578,794 | 70,778 | 2.82% | 14,392,599 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 69,330 | 69,330 | 100.00% | 386,861 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 61,826 | 61,826 | 100.00% | 344,989 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.12% | 0.00% | 152,492 | 51,340 | 50.76% | 850,905 | Jun 30, 2024 |
| MORGAN STANLEY | 0.68% | 0.00% | 894,364 | 50,843 | 6.03% | 4,990,551 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.05% | 0.00% | 60,147 | 40,240 | 202.14% | 335,620 | Jun 30, 2024 |
As of Jun 30 2024, Cytek Biosciences's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 919.85K stocks of CTKB, valued at $5.28M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -6,809,404 | -100.00% | - | Jun 30, 2024 |
| BROWN CAPITAL MANAGEMENT LLC | 8.70% | 1.28% | 11,387,384 | -634,630 | -5.28% | 63,541,603 | Jun 30, 2024 |
| DIVISADERO STREET CAPITAL MANAGEMENT, LP | - | - | - | -487,550 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 13.04% | 0.00% | 17,070,422 | -355,549 | -2.04% | 95,252,956 | Jun 30, 2024 |
| VANGUARD GROUP INC | 8.97% | 0.00% | 11,746,178 | -266,627 | -2.22% | 65,543,673 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.20% | 0.01% | 257,527 | -250,065 | -49.27% | 1,437,001 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.05% | 0.00% | 60,164 | -184,125 | -75.37% | 335,715 | Jun 30, 2024 |
| STATE STREET CORP | 3.03% | 0.00% | 3,973,132 | -142,727 | -3.47% | 22,170,077,000 | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -68,591 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -64,321 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.04% | 0.00% | 46,444 | -60,174 | -56.44% | 259,000 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.02% | 0.03% | 29,984 | -55,850 | -65.07% | 167,311 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -49,053 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.83% | 0.00% | 1,085,387 | -45,235 | -4.00% | 6,056,459,000 | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | 0.37% | 0.00% | 480,144 | -38,550 | -7.43% | 2,679,204,000 | Jun 30, 2024 |
| GRANDEUR PEAK GLOBAL ADVISORS, LLC | - | - | - | -33,131 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | 0.24% | 0.00% | 320,471 | -31,373 | -8.92% | 1,788,228 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.01% | 0.00% | 16,238 | -29,529 | -64.52% | 90,608 | Jun 30, 2024 |
| VERSOR INVESTMENTS LP | 0.02% | 0.02% | 22,400 | -24,500 | -52.24% | 124,992 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | 0.20% | 0.00% | 267,636 | -21,920 | -7.57% | 1,493,409 | Jun 30, 2024 |
As of Jun 30 2024, Cytek Biosciences's biggest institutional seller is RA CAPITAL MANAGEMENT, L.P.. The company sold -6.81M shares of CTKB, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 0.18% | 0.00% | 233,900 | 233,900 | 100.00% | 1,305,162 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.12% | 0.01% | 155,759 | 155,759 | 100.00% | 869,135 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.11% | 0.01% | 138,394 | 138,394 | 100.00% | 772,239 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 69,330 | 69,330 | 100.00% | 386,861 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 61,826 | 61,826 | 100.00% | 344,989 | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | 0.03% | 0.00% | 37,400 | 37,400 | 100.00% | 208,692 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.03% | 0.00% | 37,034 | 37,034 | 100.00% | 207,000 | Jun 30, 2024 |
| NATIXIS ADVISORS, L.P. | 0.03% | 0.00% | 35,951 | 35,951 | 100.00% | 201,000 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.02% | 0.00% | 32,333 | 32,333 | 100.00% | 180,000 | Jun 30, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 0.02% | 0.00% | 25,144 | 25,144 | 100.00% | 140,303 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.01% | 0.01% | 14,647 | 14,647 | 100.00% | 82,000 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.01% | 0.00% | 13,757 | 13,757 | 100.00% | 76,764 | Jun 30, 2024 |
| SLATESTONE WEALTH, LLC | 0.01% | 0.01% | 12,500 | 12,500 | 100.00% | 70,000 | Jun 30, 2024 |
| CERITY PARTNERS LLC | 0.01% | 0.00% | 11,815 | 11,815 | 100.00% | 65,928 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.00% | - | 1,490 | 1,490 | 100.00% | 8,000 | Jun 30, 2024 |
| CLEAR STREET MARKETS LLC | 0.00% | 0.00% | 878 | 878 | 100.00% | 5,000 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 526 | 526 | 100.00% | 2,887 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 89 | 89 | 100.00% | 497 | Jun 30, 2024 |
| HUNTINGTON NATIONAL BANK | - | - | 36 | 36 | 100.00% | 201 | Jun 30, 2024 |
| LARSON FINANCIAL GROUP LLC | - | - | 24 | 24 | 100.00% | 134 | Jun 30, 2024 |
Cytek Biosciences's largest new institutional shareholder by number of shares is RENAISSANCE TECHNOLOGIES LLC, purchased 233.90K shares, valued at $1.31M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | - | - | - | -6,809,404 | -100.00% | - | Jun 30, 2024 |
| DIVISADERO STREET CAPITAL MANAGEMENT, LP | - | - | - | -487,550 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -68,591 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -64,321 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -49,053 | -100.00% | - | Jun 30, 2024 |
| GRANDEUR PEAK GLOBAL ADVISORS, LLC | - | - | - | -33,131 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -19,844 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -15,379 | -100.00% | - | Jun 30, 2024 |
| OXFORD ASSET MANAGEMENT LLP | - | - | - | -13,726 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -13,211 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -8,377 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -6,522 | -100.00% | - | Jun 30, 2024 |
| KBC GROUP NV | - | - | - | -3,884 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -24 | -100.00% | - | Jun 30, 2024 |
Cytek Biosciences's largest sold out institutional shareholder by shares sold is RA CAPITAL MANAGEMENT, L.P., sold -6.81M shares, valued at -, as of undefined.
Cytek Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Brown Capital Management Mutual Funds | 1.51% | 4,548,308 | -2,498,724 | -35.46% | Dec 31, 2023 |
| HARTFORD HLS SERIES FUND II INC | 1.20% | 293,784 | 16,293 | 5.87% | Dec 31, 2023 |
| BlackRock Health Sciences Trust II | 0.19% | 506,752 | - | - | Mar 31, 2024 |
| ROYCE MICRO-CAP TRUST, INC. | 0.16% | 78,934 | - | - | Mar 31, 2024 |
| VANGUARD ADMIRAL FUNDS | 0.15% | 651,452 | 59,946 | 10.13% | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.14% | 71,918 | - | - | Mar 31, 2024 |
| SYNTAX ETF TRUST | 0.13% | 4,231 | 560 | 15.25% | Mar 31, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.10% | 26,270 | - | - | Jan 31, 2024 |
| BNY MELLON INDEX FUNDS, INC. | 0.09% | 101,390 | -15,970 | -13.61% | Jan 31, 2024 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.08% | 48,585 | -355 | -0.73% | Mar 31, 2024 |
| ALGER PORTFOLIOS | 0.07% | 24,335 | - | - | Dec 31, 2023 |
| Humankind Benefit Corp | 0.06% | 1,429 | 418 | 41.35% | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.06% | 240,917 | 211,888 | 729.92% | Jan 31, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.06% | 69,282 | - | - | Mar 28, 2024 |
| Vericimetry Funds | 0.06% | 5,270 | - | - | Mar 31, 2024 |
| ALGER FUNDS | 0.06% | 55,786 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.04% | 216,533 | -4,916 | -2.22% | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.03% | 165,046 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 17,615 | -980 | -5.27% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.02% | 9,220,051 | -1,399,936 | -13.18% | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.02% | 49,874 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 53,469 | 868 | 1.65% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 3,007 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 110,894 | - | - | Mar 28, 2024 |
| Securian Funds Trust | 0.01% | 83,295 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 326,494 | -3,525 | -1.07% | Jan 31, 2024 |
| HARTFORD SERIES FUND INC | 0.01% | 317,959 | 317,959 | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.01% | 28,221 | - | - | Mar 31, 2024 |
| Legg Mason ETF Investment Trust | 0.01% | 11,350 | 2,795 | 32.67% | Mar 31, 2024 |
| Ivy Variable Insurance Portfolios | 0.01% | 116,692 | - | - | Mar 28, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 962,703 | 20,682 | 2.20% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 12,042 | - | - | Mar 31, 2024 |
| VANGUARD TAX-MANAGED FUNDS | 0.00% | 759,233 | -13,804 | -1.79% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 60,553 | 14,251 | 30.78% | Jan 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 322,946 | 24,072 | 8.05% | Mar 31, 2024 |
| TIMOTHY PLAN | 0.00% | 13,134 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 33,169 | - | - | Mar 31, 2024 |
| SHELTON FUNDS | 0.00% | 4,334 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 339,376 | -583 | -0.17% | Jan 31, 2024 |
| IVY FUNDS | 0.00% | 820,019 | - | - | Mar 28, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 66,622 | -5,248 | -7.30% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 1,786 | - | - | Jan 31, 2024 |
| STEWARD FUNDS, INC. | 0.00% | 3,965 | - | - | Jan 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 7,900 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 394,270 | 94,084 | 31.34% | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 10,055 | - | - | Aug 31, 2023 |
| Catholic Responsible Investments Funds | 0.00% | 54,424 | -3,433 | -5.93% | Jan 31, 2024 |
| PRUDENTIAL SERIES FUND | 0.00% | 103,207 | -1,400 | -1.34% | Mar 28, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 40,220 | -9,241 | -18.68% | Mar 31, 2024 |
| PRAXIS MUTUAL FUNDS | 0.00% | 13,860 | -2,160 | -13.48% | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 5,905 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 500,654 | 131,377 | 35.58% | Jan 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 179,380 | 16,510 | 10.14% | Jan 31, 2024 |
| Global X Funds | 0.00% | 49,053 | - | - | Jan 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 54,948 | -1,817 | -3.20% | Dec 31, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 523,681 | 17,611 | 3.48% | Feb 29, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 632 | 53 | 9.15% | Sep 30, 2023 |
| Janus Detroit Street Trust | 0.00% | 126,850 | - | - | Jan 31, 2024 |
| North Square Investments Trust | 0.00% | 8,050 | - | - | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 12,967,814 | -360,960 | -2.71% | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 85,842 | -2,329 | -2.64% | Mar 28, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 81,712 | 71,538 | 703.15% | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,861 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 204,415 | -27,466 | -11.84% | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 42,100 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 10,000 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 39,024 | 36 | 0.09% | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 5,630 | 293 | 5.49% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 454,993 | 197,354 | 76.60% | Jan 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 4,164 | -1,921 | -31.57% | Feb 29, 2024 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 17,047 | -272 | -1.57% | Mar 31, 2024 |
| FINANCIAL INVESTORS TRUST | 0.00% | 33,131 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 51,093 | -942 | -1.81% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 7,696 | 576 | 8.09% | Mar 31, 2024 |
| ProFunds | 0.00% | 3,757 | -638 | -14.52% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 3,000 | - | - | Mar 28, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 556,374 | 67,777 | 13.87% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 1,106 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 284,670 | -5,730 | -1.97% | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 4,083 | - | - | Dec 31, 2023 |
| HC CAPITAL TRUST | 0.00% | 6,376 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 4,589 | -57 | -1.23% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND II | 0.00% | 1,294 | -1,845 | -58.78% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 46,513 | -188 | -0.40% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 4,000 | - | - | Mar 28, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 18,369 | -21,491 | -53.92% | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 61,811 | 7,075 | 12.93% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 548 | - | - | Dec 31, 2023 |
| Victory Portfolios II | 0.00% | 6,788 | - | - | Mar 31, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 472,255 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 258,535 | 5,270 | 2.08% | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 498 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 19,973 | 2,419 | 13.78% | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 4,803 | - | - | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VIII | 0.00% | 7,447 | - | - | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 15,531 | 2,944 | 23.39% | Jan 31, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 73,155 | 4,839 | 7.08% | Mar 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 13,989 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 72 | - | - | Dec 31, 2023 |
| COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.00% | 34,379 | - | - | Mar 31, 2024 |
Cytek Biosciences's largest mutual fund holder by % of total assets is "Brown Capital Management Mutual Funds", owning 4.55M shares, compromising 1.51% of its total assets.
Cytek Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 55 | -54.92% |
| 31 Mar, 24 | 122 | 19.61% |
| 31 Dec, 23 | 102 | -5.56% |
| 30 Sep, 23 | 108 | 3.85% |
| 30 Jun, 23 | 104 | 0.97% |
| 31 Mar, 23 | 103 | -1.90% |
| 31 Dec, 22 | 105 | 20.69% |
| 30 Sep, 22 | 87 | 4.82% |
| 30 Jun, 22 | 83 | 15.28% |
| 31 Mar, 22 | 72 | 41.18% |
| 31 Dec, 21 | 51 | -3.77% |
| 30 Sep, 21 | 53 | - |
As of 30 Jun 24, 55 institutions are holding Cytek Biosciences's shares, representing a decrease of -54.92% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 23,923,447 | -70.32% |
| 31 Mar, 24 | 80,592,474 | 2.10% |
| 31 Dec, 23 | 78,933,920 | 1.89% |
| 30 Sep, 23 | 77,471,030 | 0.55% |
| 30 Jun, 23 | 77,049,321 | 12.47% |
| 31 Mar, 23 | 68,508,359 | 6.95% |
| 31 Dec, 22 | 64,056,401 | 4.94% |
| 30 Sep, 22 | 61,038,144 | 15.35% |
| 30 Jun, 22 | 52,913,322 | 10.90% |
| 31 Mar, 22 | 47,713,138 | 36.17% |
| 31 Dec, 21 | 35,038,939 | 2.00% |
| 30 Sep, 21 | 34,352,026 | - |
Cytek Biosciences (CTKB) has 23.92M shares outstanding as of 30 Jun 24, down -70.32% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 18.27% | 0.51% |
| 31 Mar, 24 | 59.57% | 1.77% |
| 31 Dec, 23 | 57.97% | 1.78% |
| 30 Sep, 23 | 57.00% | 1.76% |
| 30 Jun, 23 | 56.87% | 2.22% |
| 31 Mar, 23 | 50.56% | 2.23% |
| 31 Dec, 22 | 47.62% | 2.32% |
| 30 Sep, 22 | 45.31% | 2.92% |
| 30 Jun, 22 | 39.37% | 3.10% |
| 31 Mar, 22 | 35.63% | 3.41% |
| 31 Dec, 21 | 32.35% | 3.22% |
| 30 Sep, 21 | 31.71% | - |
As of 30 Jun 24, Cytek Biosciences is held by 18.27% institutional shareholders, representing a 0.51% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 32 | -50.00% |
| 31 Mar, 24 | 64 | 12.28% |
| 31 Dec, 23 | 57 | -20.83% |
| 30 Sep, 23 | 72 | -2.70% |
| 30 Jun, 23 | 74 | 27.59% |
| 31 Mar, 23 | 58 | -12.12% |
| 31 Dec, 22 | 66 | 29.41% |
| 30 Sep, 22 | 51 | -17.74% |
| 30 Jun, 22 | 62 | 1.64% |
| 31 Mar, 22 | 61 | 96.77% |
| 31 Dec, 21 | 31 | -41.51% |
| 30 Sep, 21 | 53 | - |
32 institutional shareholders have increased their position in CTKB stock as of 30 Jun 24 compared to 64 in the previous quarter (a -50.00% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 19 | -45.71% |
| 31 Mar, 24 | 35 | 16.67% |
| 31 Dec, 23 | 30 | 30.43% |
| 30 Sep, 23 | 23 | 27.78% |
| 30 Jun, 23 | 18 | -45.45% |
| 31 Mar, 23 | 33 | 37.50% |
| 31 Dec, 22 | 24 | 20.00% |
| 30 Sep, 22 | 20 | 25.00% |
| 30 Jun, 22 | 16 | 77.78% |
| 31 Mar, 22 | 9 | - |
| 31 Dec, 21 | 9 | - |
| 30 Sep, 21 | - | - |
19 institutional shareholders have reduced their position in CTKB stock as of 30 Jun 24 compared to 35 in the previous quarter (a -45.71% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 55 | -54.92% | 23,923,447 | -70.32% | 18.27% | 0.51% | 32 | -50.00% | 19 | -45.71% |
| 31 Mar, 24 | 122 | 19.61% | 80,592,474 | 2.10% | 59.57% | 1.77% | 64 | 12.28% | 35 | 16.67% |
| 31 Dec, 23 | 102 | -5.56% | 78,933,920 | 1.89% | 57.97% | 1.78% | 57 | -20.83% | 30 | 30.43% |
| 30 Sep, 23 | 108 | 3.85% | 77,471,030 | 0.55% | 57.00% | 1.76% | 72 | -2.70% | 23 | 27.78% |
| 30 Jun, 23 | 104 | 0.97% | 77,049,321 | 12.47% | 56.87% | 2.22% | 74 | 27.59% | 18 | -45.45% |
| 31 Mar, 23 | 103 | -1.90% | 68,508,359 | 6.95% | 50.56% | 2.23% | 58 | -12.12% | 33 | 37.50% |
| 31 Dec, 22 | 105 | 20.69% | 64,056,401 | 4.94% | 47.62% | 2.32% | 66 | 29.41% | 24 | 20.00% |
| 30 Sep, 22 | 87 | 4.82% | 61,038,144 | 15.35% | 45.31% | 2.92% | 51 | -17.74% | 20 | 25.00% |
| 30 Jun, 22 | 83 | 15.28% | 52,913,322 | 10.90% | 39.37% | 3.10% | 62 | 1.64% | 16 | 77.78% |
| 31 Mar, 22 | 72 | 41.18% | 47,713,138 | 36.17% | 35.63% | 3.41% | 61 | 96.77% | 9 | - |
| 31 Dec, 21 | 51 | -3.77% | 35,038,939 | 2.00% | 32.35% | 3.22% | 31 | -41.51% | 9 | - |
| 30 Sep, 21 | 53 | - | 34,352,026 | - | 31.71% | - | 53 | - | - | - |
Cytek Biosciences Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Cytek Biosciences's stock was made by Poirson Allen on May 22 2024, selling 488 shares at $5.96 per share (valued at $2.91K).
Cytek Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 29 | 37 | 78.38% |
| Q1 2024 | 25 | 28 | 89.29% |
| Q4 2023 | 12 | 33 | 36.36% |
| Q3 2023 | 14 | 37 | 37.84% |
| Q2 2023 | 18 | 35 | 51.43% |
| Q1 2023 | 19 | 22 | 86.36% |
| Q4 2022 | 10 | 23 | 43.48% |
| Q3 2022 | 1 | 17 | 5.88% |
| Q2 2022 | 9 | 14 | 64.29% |
| Q1 2022 | 34 | 8 | 425.00% |
| Q4 2021 | 1 | 1 | 100.00% |
| Q3 2021 | 18 | 18 | 100.00% |
| Q2 2021 | - | 2 | - |
| Q4 2020 | - | 1 | - |
29 total buy trades, and 37 total sell trades (buy/sell ratio of 0.78%) were made by Cytek Biosciences's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 3 | - |
| Q1 2024 | - | 2 | - |
| Q4 2023 | - | 8 | - |
| Q3 2023 | - | 9 | - |
| Q2 2023 | - | 9 | - |
| Q1 2023 | - | 12 | - |
| Q4 2022 | - | 10 | - |
| Q3 2022 | - | 6 | - |
| Q2 2022 | - | 6 | - |
| Q1 2022 | 23 | 6 | 383.33% |
| Q4 2021 | - | - | - |
| Q3 2021 | 6 | - | - |
| Q2 2021 | - | - | - |
| Q4 2020 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 3 open market sell trades of Cytek Biosciences's stocks.
Cytek Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| TLIS | Talis Biomedical Corporation |
| APYX | Apyx Medical Corporation |
| OFIX | Orthofix Medical Inc. |
| SGHT | Sight Sciences, Inc. |
| SSKN | STRATA Skin Sciences, Inc. |
| VAPO | Vapotherm, Inc. |
| LUNG | Pulmonx Corporation |
| NPCE | NeuroPace, Inc. |
| SRDX | Surmodics, Inc. |
| LIVN | LivaNova PLC |
| KIDS | OrthoPediatrics Corp. |
| OSA | ProSomnus, Inc. Common Stock |
| AXGN | AxoGen, Inc. |
| INGN | Inogen, Inc. |
| RXST | RxSight, Inc. |
CTKB Ownership FAQ
Who Owns Cytek Biosciences?
Cytek Biosciences is owned by institutional shareholders (18.27%), insiders (8.77%), and public (72.95%). The largest institutional shareholder of Cytek Biosciences is BLACKROCK INC. (13.04% of total shares) and the top mutual fund owner is Brown Capital Management Mutual Funds (1.51% of total shares).
Who are the major institutional shareholders of Cytek Biosciences?
Cytek Biosciences's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, BROWN CAPITAL MANAGEMENT LLC, HHLR ADVISORS, LTD., and STATE STREET CORP. The top five shareholders own together 38.83% of the company's share outstanding.
How many Cytek Biosciences shareholders are there?
As of Jun 2024, there are 55 institutional shareholders of Cytek Biosciences.
What percentage of Cytek Biosciences is owned by BLACKROCK INC?
BLACKROCK INC owns 17.07M shares of Cytek Biosciences, representing 13.04% of the company's total shares outstanding, valued at $95.25M (as of Jun 2024).
What percentage of Cytek Biosciences is owned by VANGUARD GROUP INC?
As of Jun 2024, VANGUARD GROUP INC holds 11.75M shares of Cytek Biosciences (CTKB), compromising 8.97% of the company, valued at $65.54M.
What percentage of Cytek Biosciences is owned by BROWN CAPITAL MANAGEMENT LLC?
BROWN CAPITAL MANAGEMENT LLC is the third largest holder of Cytek Biosciences. The company owns 11.39M of the company's shares outstanding (worth $63.54M).